A UK study has identified which patients are likely to be unresponsive to methotrexate and may be suitable for early combination therapy. Younger adult patients with early inflammatory polyarthritis, those who are RF positive and who have higher disease activity at baseline are more likely to fail MTX treatment early due to inefficacy. The findings ...
Predictors of MTX failure allow selection of patients for early combination therapy
By Mardi Chapman
13 Apr 2018